Tapan Behl

Lovely Professional University — India

Medicine · Health Sciences

62h-index14.4kcitations498works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(46), Natural Antidiabetic Agents Studies(34), Computational Drug Discovery Methods(26), Essential Oils and Antimicrobial Activity(23), Cholinesterase and Neurodegenerative Diseases(23)

Publications498 total

ROS-responsive drug delivery systems: Harnessing redox biology for targeted therapies
Colloids and Surfaces B Biointerfaces·2026Open Access
Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy
Cancers·2026Open Access
Retraction Note: Nanosilver-functionalized polysaccharides as a platform for wound dressing
Environmental Science and Pollution Research·2025Open Access
Retraction notice to “The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis” [Life Sci. 257 (2020) 118109]
Life Sciences·2025
Retraction notice to “Understanding the possible role of endocannabinoid system in obesity" [Prostaglandins Other Lipid Mediat. 152 (2021) 106520]
Prostaglandins & Other Lipid Mediators·2025
Retraction notice to “Decrypting the potential role of α-lipoic acid in Alzheimer's disease” [Life Sci. 284 (2021) 119899]
Life Sciences·2025
Retraction notice to “Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis” [Life Sci. 258 (2020) 118164]
Life Sciences·2025
Retraction notice to “Exploring the role of biologics in depression” [Cellular Signalling 98 (2022) 110409]
Cellular Signalling·2025
Retraction notice to “Exploring the role of astrocytic dysfunction and AQP4 in depression” [Cellular Signalling 96 (2022) 110359]
Cellular Signalling·2025
Retraction Note: An update on pathophysiology and treatment of sports-mediated brain injury
Environmental Science and Pollution Research·2025Open Access
Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approaches
Progress in Neuro-Psychopharmacology and Biological Psychiatry·2025· 1 cited
In Silico ADMET Studies, Molecular Docking and MolecularDynamics Simulation of Thiadiazole Derivatives for the Identificationof Putative HsaA Monooxygenase Inhibitors
Current Medicinal Chemistry·2025· 1 cited
Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment
Current Drug Targets·2025· 1 cited
KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy
Cancers·2025· 15 citedOpen Access
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Neuroscience·2025· 8 cited
Precision Medicine in Colorectal Cancer: Targeted Therapies and Biomarker Insights
Current Cancer Drug Targets·2025· 4 cited
Unveiling the Neurotransmitter Symphony: Dynamic Shifts in Neurotransmitter Levels during Menstruation
Reproductive Sciences·2024· 13 cited
Epigenetic biomarkers in Alzheimer's disease: Diagnostic and prognostic relevance
Ageing Research Reviews·2024· 7 cited
Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders
Current Pharmaceutical Design·2024· 4 cited
Corrigendum to “Synthesis of physically crosslinked PVA/Chitosan loaded silver nanoparticles hydrogels with tunable mechanical properties and antibacterial effects” [Int. J. Biol. Macromol. 149 (2020)1262–1274]
International Journal of Biological Macromolecules·2024· 1 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Simona Bungău(38), Aayush Sehgal(18), Sukhbir Singh(18), Neelam Sharma(12), Gökhan Zengin(8), Arun Kumar(8), Saurabh Bhatia(8), Delia Mirela Ţiţ(6), Ciprian Brisc(5), Cristiana Bustea(5), Mohamed M. Abdel‐Daim(5), Ahmed Al‐Harrasi(5), Lotfi Aleya(5), Ishnoor Kaur(5), Cosmin Mihai Vesa(4), Manuela Stoicescu(4), Md. Sahab Uddin(4), Felicia Liana Andronie-Cioară(3), Mirela Mărioara Toma(3), Elena Emilia Babeş(3)